Bedaquiline Amplifies Proteasome Inhibitor Efficacy and Overcomes Resistance in Multiple Myeloma
Michela Cumerlato, Monica Maccagno, María Labrador, Beatrice Luciano, Elisabetta Mereu, Mariangela Porro, Cecilia Bandini, Mattia Furlan, Domenico Maisano, Mattia D’Agostino, Alessandra Larocca, Francesca Maria Gay, Annalaura Tamburrini, Francesca Anselmi, Paolo Ettore Porporato, , Roberto Piva
This paper identifies bedaquiline as a synergistic agent that enhances proteasome inhibitor efficacy and overcomes resistance in multiple myeloma and related B-cell malignancies.
Haematologica · Apr 23, 2026Peer-reviewedCancer Biology